Next Article in Journal
The Need to Introduce Simulation-Based Teaching in Pharmacy Education in Saudi Arabia
Next Article in Special Issue
The Effectiveness of Nonprescription Drug Labels in the United States: Insights from Recent Research and Opportunities for the Future
Previous Article in Journal
Neurocognitive, Autonomic, and Mood Effects of Adderall: A Pilot Study of Healthy College Students
Previous Article in Special Issue
Over-The-Counter (OTC) Drug Consumption among Adults Living in Germany: Results from the German Health Interview and Examination Survey for Adults 2008–2011 (DEGS1)
Article Menu
Issue 3 (September) cover image

Export Article

Open AccessArticle
Pharmacy 2018, 6(3), 59; https://doi.org/10.3390/pharmacy6030059

Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences

1
Natalie Gauld Ltd., P. O. Box 9349, Newmarket, Auckland 1149, New Zealand
2
Independent Researcher, Wellington, New Zealand
*
Author to whom correspondence should be addressed.
Received: 4 June 2018 / Revised: 24 June 2018 / Accepted: 26 June 2018 / Published: 2 July 2018
(This article belongs to the Special Issue The Standing of OTC Medicines in Community Practice)
Full-Text   |   PDF [2763 KB, uploaded 2 July 2018]   |  

Abstract

The aim of this paper was to explore pharmacists’ views on reclassifications from pharmacy-only to general sales and their experiences with the supply of these medicines, in addition to pharmacists’ views on the reclassification of the shingles vaccine and sildenafil to be available through ‘accredited’ pharmacists. New Zealand community pharmacists were surveyed in 2013 with a written questionnaire of six Likert-style or open-ended questions sent to Pharmacy Guild member pharmacies. The analysis involved descriptive statistics. Responses were received from 246 pharmacies. Two thirds of pharmacists supported the reclassification of the shingles vaccine and sildenafil, although 14% disagreed with the sildenafil reclassification. Over 90% of pharmacists disagreed with the reclassification of paracetamol and ibuprofen liquids, omeprazole, naproxen, and oxymetazoline from pharmacy-only medicine to general sales. This opinion was strongest for omeprazole. With liquid paracetamol and ibuprofen, pharmacists described consumer confusion with dosing, and particularly potentially doubling-up on liquid analgesics/antipyretics including using both prescription and non-prescription variants. Many reported giving safety advice frequently. Anti-inflammatories and omeprazole were also subject to potential double-dosing, as well as requests by consumers with contraindications, precautions, and drug interactions, and for inappropriate indications. Pharmacists described various interventions, including some that were potentially life-saving. Pharmacy availability of medicines provides the potential for intervention that would not happen in a general sales environment. View Full-Text
Keywords: community pharmacy; non-prescription drugs; reclassification; self-medication; pharmacist intervention community pharmacy; non-prescription drugs; reclassification; self-medication; pharmacist intervention
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Gauld, N.; Sullivan, T. Double-Dosing and Other Dangers with Non-Prescription Medicines: Pharmacists’ Views and Experiences. Pharmacy 2018, 6, 59.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top